| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| OCULAR THERAPEUTIX, INC | Chief Medical Officer | Common Stock | 247K | $3.12M | $12.62 | Aug 12, 2025 | Direct |
| OCULAR THERAPEUTIX, INC | Chief Medical Officer | Stock Option (Right to Buy) | 123K | Aug 12, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| OCUL | OCULAR THERAPEUTIX, INC | Aug 12, 2025 | 2 | $0 | 4 | Aug 14, 2025 | Chief Medical Officer |
| OCUL | OCULAR THERAPEUTIX, INC | Jun 2, 2025 | 1 | -$112K | 4 | Jun 3, 2025 | Chief Medical Officer |
| OCUL | OCULAR THERAPEUTIX, INC | Feb 11, 2025 | 2 | $0 | 4 | Feb 13, 2025 | Chief Medical Officer |
| OCUL | OCULAR THERAPEUTIX, INC | Jun 1, 2024 | 2 | $0 | 4 | Jun 4, 2024 | Chief Medical Officer |
| OCUL | OCULAR THERAPEUTIX, INC | Jun 1, 2024 | 0 | $0 | 3 | Jun 4, 2024 | Chief Medical Officer |